Edwards Lifesciences Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
2024-12-31

DJ Edwards Lifesciences Corp. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Edwards Lifesciences Corp. $(EW)$ slid 1.86% to $74.24 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.07% to 5,906.94 and Dow Jones Industrial Average falling 0.97% to 42,573.73.

This was the stock's second consecutive day of losses.

Edwards Lifesciences Corp. closed $21.88 short of its 52-week high ($96.12), which the company achieved on March 28th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Abbott Laboratories $(ABT)$ fell 1.90% to $112.80, Medtronic PLC $(MDT)$ fell 1.40% to $79.61, and Stryker Corp. $(SYK)$ fell 1.32% to $362.26.

Trading volume (2.4 M) remained 2.8 million below its 50-day average volume of 5.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled December 30, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

December 30, 2024 16:56 ET (21:56 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10